According to FutureWise analysis the market for Drug Discovery Services in 2023 was US$ 19.70 billion, and is expected to reach US$ over 65 billion by 2031 at a CAGR of 14.50%.
The process of designing new drugs is known as drug discovery. This field employs various methodologies, including molecular manipulation, random screening, drug metabolite analysis, molecular design, and sometimes serendipity. Drug discovery services aim to minimize both costs and timelines associated with developing new medications. These methods are utilized across pharmacology, biotechnology, and medicine to identify and create innovative treatments. The drug discovery process involves several key steps, such as identifying potential drug candidates, producing them, depicting their molecular structures, selecting the most promising candidates, and conducting assays to assess their therapeutic potential. Once a compound is validated through these evaluations, it progresses to drug development, eventually leading to clinical trials.
Core components of drug discovery services include drug target identification, the selection of compounds, fragment-based drug design, lead compound recognition, and optimization of promising leads. These services are also instrumental in fields such as forensics, paternity testing, disaster victim identification, and anthropology, where DNA analysis plays a crucial role.The market for drug discovery services is experiencing rapid growth, driven by increased research and development (RD) spending, a trend among major pharmaceutical companies to outsource to mitigate challenges, and a rising demand for analytical testing and clinical trial services. This expansion is further fueled by technological advancements, the adoption of new discovery methodologies, a heightened demand for generic medications, and the expiration of numerous patents Encouraging factors for this market include increased RD activities, the growth of the healthcare sector, demographic shifts such as an aging population, and innovations in drug discovery services, all contributing to the sector's overall expansion.
Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=3465%20type=requestsample
Drug Discovery Services Market Segmentation:
By Process
- Target Selection
- Target Validation
- Hit-to-Lead Identification
- Lead Optimization
- Candidate Validation
By Type
- Medicinal Chemistry
- Biology Services
- Drug Metabolism and Pharmacokinetics
By Drug Type
- Small Molecules
- Biologics
By Therapeutic Area
- Oncology
- Neurology
- Cardiovascular Diseases
- Respiratory Diseases
- Diabetes
- Other Therapeutics Areas
By Company Type
- Tier 1 Pharmaceutical Companies
- Tier 2 Pharmaceutical Companies
- Tier 3 Pharmaceutical Companies
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Drug Discovery Services Market:
- Thermo Fisher Scientific
- Merck
- GE Healthcare
- Albany Molecular Research, Inc (AMRI)
- Charles River Laboratories International
- Evotec
- Pharmaceutical Product Development, LLC. (Ppd)
- Jubilant Biosys
- Covance
- Genscript Biotech Corporation
- Aurigene Discovery Technologies
- Wuxi Apptec
- Syngene
- Eurofins Scientific
- GVK Biosciences Private Limited
- Laboratory Corporation of America Holdings
- Lonza Group AG
- Piramal Enterprises Ltd
- Viva Biotech
- Dalton Pharma Services
- Domainex
- Selvita S.A.
- SRI International
- BioDuro
Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=3465license=multi
**Objectives of this Study: **
- To provide a comprehensive analysis of the Drug Discovery Services Market By Process, By Type, By Drug Type, By Therapeutic Area, By Company Type and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
